Jpmorgan Chase & Co »

Tenax Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $142k 11k 13.50
2026-03-31 $132k 9.4k 14.01

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Tenax Therapeutics

FMR
T. Rowe Price Associates
Vivo Capital
Henderson Group
BlackRock
Perceptive Advisors
Ikarian Capital
Vanguard Capital Management
Citadel Advisors
Millennium Management
Candriam Luxembourg S.C.A.
Caption Management
Rtw Investments
Stonepine Capital Management
Geode Capital Management

View all funds holding Tenax Therapeutics